一心堂 (002727)

Yixintang Pharmaceutical Group Co., Ltd.

ASZ

Tags

MSCI Mid Cap IndexCSI Share Buyback IndexElderly Care ConceptGambling ConceptInfant and Child ConceptNew RetailSmart HealthcareVocational EducationShareholder ReductionFree Cash FlowMargin Trading and Securities LendingCross-Border E-commerceRetailSME 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 58560.41
  • Circulating A-Shares(W): 39731.24
  • Earnings Per Share(RMB): 0.4587
  • Net Assets Per Share(RMB): 12.4949
  • Operating Revenue(W RMB): 1300102.90
  • Total Profit(W RMB): 36260.52
  • Net Profit Attributable to Parent(W RMB): 26859.20
  • Net Profit Growth Rate(%): -8.17
  • Weighted Return on Equity(%): 3.6100
  • Operating Cash Flow Per Share(RMB): 2.4460
  • Undistributed Profit Per Share(RMB): 7.6907
  • Capital Reserve Per Share(RMB): 3.4379

2. Main Business

The main business covers:

  • Pharmaceutical retail chain
  • Pharmaceutical distribution

3. Company Basic Information

  • Company Name: Yixintang Pharmaceutical Group Co., Ltd.
  • Listing Date: 2014-07-02
  • Industry: Retail
  • Address: No.1 Hongxiang Road, Economic and Technological Development Zone, Kunming City, Yunnan Province
  • Website: www.hx8886.com
  • Company Profile: The Company was established through the overall change of Yunnan Hongxiang Pharmaceutical Co., Ltd., which was founded on November 8, 2000. On May 10, 2009, Hongxiang Pharmaceutical held its first interim shareholders' meeting in 2009, and all shareholders unanimously agreed to change Hongxiang Pharmaceutical into a joint stock company. Based on the net assets of Hongxiang Pharmaceutical as of December 31, 2008, which amounted to 176,666,248.19 yuan, the company's capital stock was converted into 175,680,000.00 shares, and the remaining net assets of 986,248.19 yuan were converted into capital reserve. On June 18, 2009, the Company obtained the Business License for Enterprise Legal Person (Registration No.: 530000100018401) issued by the Yunnan Provincial Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. General Legal Person 3088.03 7.77
2 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2231.44 5.62
3 Rongtong Health Industry Flexible Allocation Hybrid Securities Investment Fund Class A Fund 1650.00 4.15
4 Xingquan Trend Investment Hybrid Securities Investment Fund (LOF) Fund 600.00 1.51
5 Xingquan Hetai Hybrid Securities Investment Fund Class A Fund 486.31 1.22
6 Xingzheng Global Heheng Three-Year Holding Period Hybrid Securities Investment Fund Class A Fund 379.57 0.96
7 Rongtong Xinxin Growth Hybrid Securities Investment Fund Class A Fund 370.00 0.93
8 Rongtong China Wind No.1 Flexible Allocation Hybrid Securities Investment Fund Class A Fund 360.90 0.91
9 SDIC UBS Ruili Flexible Allocation Hybrid Securities Investment Fund (LOF) Class A Fund 246.50 0.62
10 SDIC UBS Optimization Enhanced Bond Securities Investment Fund Class A Fund 239.54 0.60

5. Concept Sectors

  • New Retail
  • Infant & Child Concept
  • Elderly Care Concept
  • Gambling Concept
  • Vocational Education
  • Smart Healthcare
  • Cross-border E-commerce
  • Margin Trading & Securities Lending
  • Shareholder Reduction
  • MSCI Mid Cap
  • Free Cash Flow
  • SME 300 Index
  • CSI Buyback Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information